BioSpace News Archive

NervGen Pharma Corp. (TSXV: NGEN) (OTCQB: NGENF) (“NervGen” or the “Company”), a regenerative medicine company dedicated to creating innovative solutions for the treatment of nerve damage, including spinal cord and peripheral nerve injury, today announced that it has appointed Denis Bosc, PhD, as the Company’s Vice President, Chemistry, Manufacturing and Control (CMC)

Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromuscular and neurological diseases, today announced that it has amended its license agreement for Firdapse® to expand its commercial territory.

The Company’s management will be participating in the 39th Annual William Blair Growth Stock Conference in Chicago.

Arizona company claims their products can treat Lyme disease, diabetes, Parkinson’s disease and more, but have not been approved for any use

First-of-its-Kind Cyclic IMS Provides Unlimited Experimental Opportunities while the Research-Grade SYNAPT XS Brings Analytical Flexibility

Tri-State Effort Touts Life Sciences Assets to Attract More Companies, Talent and Investment

The study, conducted in collaboration with the University of Michigan utilizing Epic’s CTC technology platform, is published here in the Journal of Clinical Oncology Precision Oncology.

Rensselaer Polytechnic Institute (RPI), America’s first technological research university, has found increased efficiencies in multiple critical areas after performing a complete digital transformation utilizing JAGGAER’s advanced Enterprise Reagent Manager (ERM).

Veeva Systems announced participation in the following investor conferences

Kodiak Sciences Inc. announced that management will present at the Jefferies 2019 Healthcare Conference in New York, NY on Thursday, June 6 at 2:00 p.m. Eastern Time.